Goldman Sachs’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|
|||||
|
2021
Q4 | $123K | Sell |
|
|||||
|
2021
Q3 | $366K | Buy |
|
|||||
|
2021
Q2 | $334K | Sell |
|
|||||
|
2021
Q1 | $2.49M | Buy |
|
|||||
|
2020
Q4 | $1.39M | Sell |
|
|||||
|
2020
Q3 | $3.31M | Buy |
|
|||||
|
2020
Q2 | $605K | Buy |
|
|||||
|
2020
Q1 | $505K | Sell |
|
|||||
|
2019
Q4 | $2.29M | Buy |
|
|||||
|
2019
Q3 | $1.19M | Sell |
|
|||||
|
2019
Q2 | $1.27M | Sell |
|
|||||
|
2019
Q1 | $3.43M | Buy |
|
|||||
|
2018
Q4 | $1.9M | Sell |
|
|||||
|
2018
Q3 | $3.68M | Sell |
|
|||||
|
2018
Q2 | $4.16M | Buy |
|
|||||
|
2018
Q1 | $2.31M | Buy |
|
|||||
|
2017
Q4 | $2.76M | Buy |
|
|||||
|
2017
Q3 | $2.22M | Buy |
|
|||||
|
2017
Q2 | $1.84M | Sell |
|
|||||
|
2017
Q1 | $2.77M | Buy |
|
|||||
|
2016
Q4 | $1.16M | Buy |
|
|||||
|
2016
Q3 | $973K | Buy |
|
|||||
|
2016
Q2 | $743K | Sell |
|
|||||
|
2016
Q1 | $793K | Sell |
|
|||||
|
2015
Q4 | $3.08M | Sell |
|
|||||
|
2015
Q3 | $2.75M | Buy |
|
|||||
|
2015
Q2 | $900K | Sell |
|
|||||
|
2015
Q1 | $1.07M | Buy |
|
|||||
|
2014
Q4 | $167K | Sell |
|
|||||
|
2014
Q3 | $2.01M | Buy |
|
|||||
|
2014
Q2 | $97K | Sell |
|
|||||
|
2014
Q1 | $1.45M | Buy |
|
|||||
|
2013
Q4 | $1.13M | Buy |
|
|||||
|
2013
Q3 | $206K | Sell |
|
|||||
|
2013
Q2 | $580K | Buy |
|